Yahoo Finance's Julia La Roche sits down with executive chairman and former CEO of Starbucks Howard Schultz
|Bid||35.92 x 700|
|Ask||36.00 x 700|
|Day's Range||35.77 - 36.12|
|52 Week Range||29.83 - 36.21|
|PE Ratio (TTM)||26.31|
|Dividend & Yield||1.28 (3.61%)|
|1y Target Est||N/A|
The U.S. opioid crisis rages on. TheStreet takes a look at several drugs being used to help treat people.
One biopharma's loss is another biopharma's gain when it comes to rare disease drug trials.
Bernstein sees opportunity in a buyout target.